Spotlight
Commentary
Cultural Corner
Psychiatric Practice
Series
News
Job Board
CME/CE
Partners
Editorial
Subscribe
Grethel Perez Meek, DO
Articles
Phase 3 Trials Examine Gantenerumab for Early Alzheimer Disease
Meagan Kubista, MD;Grethel Perez Meek, DO;Kyle Sramek, MD;Mark Mullen, MD;Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP
February 20th 2024Two phase 3 trials were conducted to assess the clinical and biological effects as well as the safety of gantenerumab in individuals with mild cognitive impairment or mild dementia due to AD. Here's what you need to know.
Latest Updated Articles
Published: August 3rd 2015 | Updated: November 23rd 2024
Mini Quiz: DSM-5 Basics
Published: March 19th 2021 | Updated: November 23rd 2024
Mini Quiz: Treatment for Pedophilia?
Published: January 21st 2016 | Updated: November 23rd 2024
Mini Quiz: Methods of Suicide
Published: March 23rd 2021 | Updated: November 23rd 2024
Poor DSM-5—So Misunderstood!
Published: January 23rd 2017 | Updated: November 23rd 2024
Mini Quiz: Characterizing Sexual Deviation
Published: June 6th 2018 | Updated: November 23rd 2024
Mini Quiz: Psychogenic Non-Epileptic Seizures
